Study in nursing homes shows rapid antigen testing could be a useful tool to identify contagious people at risk for transmitting SARS-CoV-2
Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak – Annals of Internal Medicine Editorial: Utility of Rapid Antigen Tests in Nursing Homes Commentary on Twitter ?? Despite lower positive agreement compared with RT-PCR, antigen test positivity had higher agreement with shedding of replication-competent virus. These results suggest that antigen […]
The post Study in nursing homes shows rapid antigen testing could be a useful tool to identify contagious people at risk for transmitting SARS-CoV-2 appeared first on Links Medicus.
M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, it remains very uncertain whether ivermectin reduces SARS-CoV-2 infection
Prophylaxis against covid-19: living systematic review and network meta-analysis – The BMJ
The post M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, it remains very uncertain whether ivermectin reduces SARS-CoV-2 infection appeared first on Links Medicus.
ACP Guideline: Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings
Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings: A Clinical Guideline From the American College of Physicians – Annals of Internal Medicine
The post ACP Guideline: Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings appeared first on Links Medicus.
U.S. lifts pause on use of J&J’s Covid-19 vaccine
U.S. lifts pause on use of J&J’s Covid-19 vaccine – STAT See also: CDC, FDA lift pause on using J&J’s coronavirus vaccine, add safety warning – CNN AND ACIP opts to lift pause on Johnson & Johnson vaccine – CIDRAP
The post U.S. lifts pause on use of J&J’s Covid-19 vaccine appeared first on Links Medicus.
Multicenter cohort study shows survival among ECMO-assisted patients is strongly associated with center experience
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study – The Lancet Respiratory Medicine Invited commentary: COVID-19 and ECMO: a call for close cooperation and more investigation – The Lancet Respiratory Medicine Commentary on Twitter #ECMO network & outcomes during #COVID19 #pandemic in […]
The post Multicenter cohort study shows survival among ECMO-assisted patients is strongly associated with center experience appeared first on Links Medicus.
Covid-19: What do we know about airborne transmission of SARS-CoV-2?
Covid-19: What do we know about airborne transmission of SARS-CoV-2? – The BMJ Related: Ten scientific reasons in support of airborne transmission of SARS-CoV-2 AND Editorial: Covid-19 has redefined airborne transmission
The post Covid-19: What do we know about airborne transmission of SARS-CoV-2? appeared first on Links Medicus.
Case series of 18 male adults aged 50 years or younger with acute ischemic stroke during the convalescent phase of asymptomatic Covid-19
Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men – JAMA Network Open Commentary: ‘The next wave of complications’: Asymptomatic COVID-19 patients face a prolonged stroke risk – Cardiovascular Business Commentary on Twitter A ?? case series highlights that adults 50 years or younger with asymptomatic COVID-19 infection diagnosed by […]
The post Case series of 18 male adults aged 50 years or younger with acute ischemic stroke during the convalescent phase of asymptomatic Covid-19 appeared first on Links Medicus.
RCT: COVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir
COVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir – CIDRAP Original study: Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial – JAMA Network Open Commentary on Twitter (thread – Click for more) 1/ No benefit from Hydroxychloroquine or Lopinavir-Ritonavir on […]
The post RCT: COVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir appeared first on Links Medicus.
Covid-19: More data on the increased risks to pregnant women and their newborn infants
Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study – JAMA Pediatrics Editorial: COVID-19 in Pregnant Women and Their Newborn Infants Commentaries: Pregnant women with COVID-19 face high mortality rate – University of Washington School of Medicine AND Covid-19 raises risks for expectant mothers and […]
The post Covid-19: More data on the increased risks to pregnant women and their newborn infants appeared first on Links Medicus.
NIH Updates COVID-19 Treatment Guidelines – adds recommendations on colchicine, fluvoxamine, and monoclonal antibodies
NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health
The post NIH Updates COVID-19 Treatment Guidelines – adds recommendations on colchicine, fluvoxamine, and monoclonal antibodies appeared first on Links Medicus.